Battelle breakthrough could help autistic children receive treatment sooner

Battelle scientists have identified a low-cost urine test that potentially predicts the presence of autism spectrum disorder (ASD) at an early age.

ASD, which is defined by behavioral characteristics, has been difficult for physicians to diagnose at an early age before these behaviors become more apparent (usually about two years of age or older). Recent research indicates that ASD affects 1 in 88 children in the U.S.

The Battelle team of Drs. Nicholas Heyer and Diana Echeverria joined with Professor James Woods at the University of Washington’s School of Public Health to evaluate the levels of porphyrins in the urine of children with ASD to determine if certain levels of specific porphyrins could predict ASD.

Identifying this link may have important clinical implications for diagnosis and treatment. The ability to detect porphyrins, a group of naturally occurring organic compounds, in a simple urine test allows for a rapid, low-cost and widely used screening test for identifying young children at a high risk for ASD.

“This is significant because it means children may be diagnosed with ASD at an earlier age and can thus receive treatment sooner. Early treatment can lead to a better quality of life for children with ASD,” Heyer said.

The findings were published in this month’s edition of Autism Research, and coincide with Autism Awareness Month.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Northeast Ohio Medical University (NEOMED) and Mercy Health team up on scholarship program | IndeOnline, December 17, 2014

New distribution partnership between Ganeden Biotech and Grupo Saporiti will increase availability of GanedenBC30 in South America | Ganeden Biotech, December 17, 2014

Sparton acquires Industrial Electronic Devices, makers of ruggedized displays for electronics | Business Wire, December 17, 2014

Columbus downtown building where cancer drugs were once made might be demolished | The Columbus Dispatch, December 17, 2014

Health and Human Services awards Ohio $75 million to implement and test health care payment and service delivery models, improve care, lower costs | Ohio Hospital Association, December 16, 2014

Tedia chairman Elinora Park honored by the Cincinnati Regional Chamber of Commerce | PR Web, December 16, 2014

Cleveland HeartLab is the fastest growing private health care company in the Cleveland metro area according to Inc. | Inc., December 16, 2014

US Endoscopy announces distribution agreement for the EndoRings device | US Endoscopy, December 16, 2014

CincyTech portfolio companies raising $200 million in investor capital by end of 2014 | Cincinnati.com, December 16, 2014

Data presented by independent academic collaborators demonstrate ability of novel Manocept Immunotherapy to kill activated macrophages from KS patients, Macrophage Therapeutics, Navidea Biopharmaceuticals | Business Wire, December 15, 2014

Clinical Research Management (ClinicalRM) announces clinical trial evaluating effectiveness of convalescent plasma therapy for the treatment of Ebola underway in Liberia | PR Newswire, December 15, 2014

Alkermes announces initiation of clinical study of extended durations of Aripiprazole Lauroxil for treatment of schizophrenia | Business Wire, December 15, 2014

Ohio Northern University receives $1.21 million grant to instill the entrepreneurial mindset in engineering undergraduates | PR Newswire, December 15, 2014

Nationwide Children’s and OhioHealth planning campus in Delaware County | Columbus Business First, December 15, 2014

Akron couple donates $2 million for cancer research and education at Summa Health System | Akron Beacon Journal, December 13, 2014

Battelle, The Ohio State University and the Ohio Soybean Council developing improved soybean meal for aquaculture | The Fish Site, December 12, 2014

Wright-Patterson AFB Air Force Research Laboratory to hire 325 scientists and engineers in the next year | Dayton Daily News, December 12, 2014

Navidea’s Macrophage Therapeutics to present data supporting potential for breakthrough with Manocept in immunotherapy | Navidea Biopharmaceuticals, December 12, 2014

Midmark has acquired Mumbai, India-based Janak Healthcare | Dayton Business Journal, December 11, 2014

Navidea forms Macrophage Therapeutics business unit to explore therapeutic applications of Manocept | Navidea Biopharmaceuticals, December 10, 2014